Cite
HARVARD Citation
Kakinuma, K. et al. (2018). Differences in skeletal muscle loss caused by cytotoxic chemotherapy and molecular targeted therapy in patients with advanced non‐small cell lung cancer. Thoracic cancer. 9 (1), pp. 99-104. [Online].